Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India.
Pierneef L, Malaviya P, van Hooij A, Sundar S, Singh AK, Kumar R, de Jong D, Meuldijk M, Kumar A, Zhou Z, Cloots K, Corstjens P, Hasker E, Geluk A. Pierneef L, et al. Among authors: sundar s. Front Med (Lausanne). 2023 Sep 27;10:1260375. doi: 10.3389/fmed.2023.1260375. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37828950 Free PMC article.
Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review.
Chhajed R, Dahal P, Singh-Phulgenda S, Brack M, Naylor C, Sundar S, Alves F, Stepniewska K, Guerin PJ. Chhajed R, et al. Among authors: sundar s. Lancet Reg Health Southeast Asia. 2023 Dec 6;22:100317. doi: 10.1016/j.lansea.2023.100317. eCollection 2024 Mar. Lancet Reg Health Southeast Asia. 2023. PMID: 38482151 Free PMC article.
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
Singh-Phulgenda S, Kumar R, Dahal P, Munir A, Rashan S, Chhajed R, Naylor C, Maguire BJ, Siddiqui NA, Harriss E, Rahi M, Alves F, Sundar S, Stepniewska K, Musa A, Guerin PJ, Pandey K. Singh-Phulgenda S, et al. Among authors: sundar s. PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0011635. doi: 10.1371/journal.pntd.0011635. eCollection 2024 Apr. PLoS Negl Trop Dis. 2024. PMID: 38626228 Free PMC article.
A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.
Edwards CL, Engel JA, de Labastida Rivera F, Ng SS, Corvino D, Montes de Oca M, Frame TC, Chauhan SB, Singh SS, Kumar A, Wang Y, Na J, Mukhopadhyay P, Lee JS, Nylen S, Sundar S, Kumar R, Engwerda CR. Edwards CL, et al. Among authors: sundar s. JCI Insight. 2023 Dec 22;8(24):e169362. doi: 10.1172/jci.insight.169362. JCI Insight. 2023. PMID: 37917177 Free PMC article.
Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis.
Kumar R, Dahal P, Singh-Phulgenda S, Siddiqui NA, Munir A, Naylor C, Wilson J, Buck G, Rahi M, Malaviya P, Alves F, Sundar S, Ritmeijer K, Stepniewska K, Guérin PJ, Pandey K. Kumar R, et al. Among authors: sundar s. BMJ Open. 2023 Oct 28;13(10):e074679. doi: 10.1136/bmjopen-2023-074679. BMJ Open. 2023. PMID: 37898487 Free PMC article.
1,176 results